New EMA guideline: Handling and shipping of IMPs [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2018-05-24 15:45 (1242 d 10:47 ago) – Posting: # 18814
Views: 1,898

Dear all,

today the EMA published the “Draft guideline on the responsibilities of the sponsor with regard to handling and shipping of investigational medicinal products for human use in accordance with Good Clinical Practice and Good Manufacturing Practice”. End of consultation is on 31 August 2018.

Have also a look at the applicable guidelines on Good Distribution Practice (GDP):

Dif-tor heh smusma 🖖
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

 Admin contact
21,731 posts in 4,544 threads, 1,543 registered users;
online 3 (0 registered, 3 guests [including 3 identified bots]).
Forum time: Monday 02:32 CEST (Europe/Vienna)

Law is mind without reason.    Aristotle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz